Skip to main content
Equibles

VANGUARD CAPITAL MANAGEMENT LLC

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 2100119 MALVERN, PA
Back to BTAI Full portfolio

Position in BTAI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,296,558
+$1,018,724 QoQ
Shares Held
919,545
+343.5% QoQ
Ownership
2.94%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 47 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VANGUARD CAPITAL MANAGEMENT LLC holds $8,313,887,454 across 56 Drug Manufacturers - Specialty & Generic names. BTAI ranks #43 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 26,027,984 $1,870,370,930
2 VTRS
Viatris Inc
 76,046,939 $1,207,625,391
3 UTHR
UNITED THERAPEUTICS Corp
 1,918,256 $1,039,368,648
4 NBIX
Neurocrine Biosciences Inc
 4,545,339 $766,071,435
5 ELAN
Elanco Animal Health Inc
 22,607,532 $556,371,362
6 ALKS
Alkermes plc.
 7,515,025 $393,787,310
7 HIMS
Hims & Hers Health, Inc.
 9,541,384 $330,799,783
8 LNTH
Lantheus Holdings, Inc.
 2,932,214 $325,299,821

All Filings in BTAI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,296,558 919,545
2026-03-31 $277,834 207,339